Polyphosphazene delivery system for inorganic nanocrystals
US10940217B2 · kind B2 · utility
Assignees
Inventors
Key dates
| Filing date | Mar 18, 2015 |
| Grant date | Mar 9, 2021 |
| Priority date | — |
| Expiry date | Mar 18, 2035 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61N2005/1098
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Nanoclusters comprising inorganic nanocrystals and a biodegradable polymer are disclosed. The inorganic nanocrystals have a mean particle size of 1 to 500 nm. The inorganic nanocrystals are contained within a core of the nanoclusters, on the surface of the nanoclusters, contained within a core of the nanoclusters, dispersed throughout the nanoclusters, or a combination thereof. The biodegradable polymer allows the inorganic nanocrystals to be excreted renally over a period of time. The nanoclusters can be used for medical imaging or other biomedical applications.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.